Antisense Oligonucleotides (ASOs): RNA-Based Precision in Retinitis...

agregó una foto Health

2025-12-02 10:52:46 -

Antisense Oligonucleotides (ASOs): RNA-Based Precision in Retinitis Pigmentosa Treatment

RNA-based therapies, specifically Antisense Oligonucleotides (ASOs), are emerging as a powerful and highly precise class of molecules for treating certain genetic forms of Retinitis Pigmentosa (RP). ASOs are short, synthetic chains of nucleic acids designed to bind to a specific sequence of the patient's messenger RNA (mRNA). By binding to this target RNA, the ASO can modify how the genetic...

0 Commentarios 0 Acciones 239 Views 0 Vista previa